* Guardant Health Inc GH.OQ reported a quarterly adjusted
loss
of 90 cents per share for the quarter ended December 31, lower
than the same quarter last year, when the company reported EPS
of -64 cents. The mean expectation of twenty three analysts for
the quarter was for a loss of 74 cents per share. Wall Street
expected results to range from $-1.02 to -45 cents per share.
* Revenue rose 30.2% to $201.81 million from a year ago;
analysts
expected $192.14 million.
* Guardant Health Inc's reported EPS for the quarter was a
loss
of 90 cents.
* The company reported a quarterly loss of $111.01 million.
* Guardant Health Inc shares had risen by 55.2% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 6.4%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 22 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Guardant Health
Inc is $47.00
This summary was machine generated from LSEG data February 21 at
05:06 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2024 -0.74 -0.90 Missed
Sep. 30 2024 -0.74 -0.88 Missed
Jun. 30 2024 -0.74 -0.84 Missed
Mar. 31 2024 -0.85 -0.94 Missed